• Donald S. Chisum, Craig Allen Nard, Herbert F. Schwartz, Pauline Newman, and F. Scott Kieff, Principles of Patent Law: Cases and Materials (Foundation Press, 2001) (abbreviated "CNSNK")
• William Fisher, Supplemental Materials on Patent Law (2004) (abbreviated "Supp")

A. Trade Secrets:  The Alternative to Patents (Feb. 2-3)

• Uniform Trade Secrets Act [Supp I 1-3]
• American Credit Indemnity Co. v. Sacks, 213 Cal. App. 3d 622 (Cal. Ct. App. 1989) [Supp I 4-14]
• S.O.S., Inc. v. Payday, Inc., 886 F.2d 1081 (CA9 1989) [Supp I 15-18]
• E.I. Dupont deNemours & Co. v. Christopher, 431 F.2d 1012 (5th Cir. 1970) [Supp I 19-22]
• Sheets v. Yamaha Motors Corp., 849 F.2d 179 (CA5 1988) [Supp I 23-28]
• Integrated Cash Management Services v. Digital Transactions, Inc., 920 F.2d 171 (CA2 1990) [Supp I 29-31]
• Lamb-Weston, Inc. v. McCain Foods, Ltd., 941 F.2d 970 (CA9 1991) [Supp I 32-34]
• Robert G. Bone, A New Look at Trade Secret Law: Doctrine in Search of Justification, 86 Calif. L. Rev. 241, 262-83 (1998) [Supp I 35-46]
• Lynn Sharp Paine, "Trade Secrets and the Justification of Intellectual Property," 20 Philosophy & Public Affairs 247 (1991) [Supp I 47-55]

B. The Origins and Internationalization of Patent Law

• "A History of Patent Law"  [CNSNK 6-30]
• Gerald Mossinghoff, "The Creation of the Federal Circuit"  [CNSNK 30-31]
• Paul Goldstein, International Intellectual Property Law, 297-300  [Supp I 56-59]
• Joseph Straus, "Implications of the TRIPS Agreement in the Field of Patent Law," in From Gatt to TRIPS: The Agreement on Trade-Related Aspects of Intellectual Property Rights 160, 170-75 (1996)  [Supp I 59-62]
• Agreement on Trade-Related Aspects of Intellectual Property Rights, Articles 27-34 [Supp I 63-66]

A. Utility Patents

• Gottshalk v. Benson, 409 U.S. 63 (1972) [CNSNK 730-35]
• Parker v. Flook, 437 U.S. 584 (1978) [CNSNK 739-46]
• Diamond v. Chakrabarty, 447 U.S. 303 (1980) [CNSNK 747-57]
• Ananda M. Chakrabarty, "Diamond v. Chakrabarty: A Historical Perspective" [CNSNK 758-63]
• Diamond v. Dehr, 450 U.S. 175 (1981) [CNSNK 763-76]
• In re Alappat, 33 F.3d 1526 (CAFC 1994) [CNSNK 790-807]
• State Street Bank and Trust Co. v. Signature Financial Group, 149 F.3d 1368 (CAFC 1998) [CNSNK 808-818]
• Lawrence Lessig, "Online Patents: Leaving them Pending," Wall Street Journal, March 23, 2000 [Supp II 1-3]
• Notes 1-4 [CNSNK 818-21]
• Arti Rai & Rebecca Eisenberg, "Bayh-Dole Reform and the Progress of Biomedicine," 91 American Scientist 52 (2003) [handout]
• American Medical Association, Council on Ethical and Judicial Affairs, "Ethical Issues in the Patenting of Medical Procedures," 53 Food Drug L.J. 341 (1998) [Supp II 4-14]
• Note on Sports Patents [CNSNK 821-28]
• Carlos Correa, "The GATT Agreement on Trade-Related Aspects of Intellectual Property Rights:  New Standards for Patent Protection," 16 European Intellectual Property Review 327 (1994), G 303-07 [Supp II 15-19]
• Paul Goldstein, International Intellectual Property Law, 307-11 [Supp II 19-23]
• Robert Merges, "Intellectual Property in Higher Life Forms: The Patent System and Controversial Technologies," 47 Md. L. Rev. 1051 (1988) [Supp II 24-36]
• William Fisher, "The Growth of Intellectual Property: A History of the Ownership of Ideas in the United States," in Eigentum im internationalen Vergleich (Vandenhoeck & Ruprecht, 1999), 265-91 [Supp II 37-59]

B. Plant Patents

• Robert Merges, Note on Plants, in Patent Law and Policy (2d ed. 1997), 164-65 [Supp II 60-61]
• Ex Parte Hibberd, 227 U.S.P.Q.2d (Pat. Off. Bd. App. 1985) [Supp II 61-65]
• Merges, Patent Law and Policy, 169-74 [Supp II 65-70]
• Pioneer Hibred, 122 S. Ct. 593 (2001) [Supp II 71-79]
• William Fisher, "The Impact of 'Terminator Gene' Technologies on Developing Countries," Report to the UK Department for International Development, December 1999 [Supp II 80-90]

C. Design Patents

• Avia Group International v. L.A. Gear California, 853 F.2d 1557 (Fed. Cir. 1988) [Supp II 91-96]
• Merges et al., "Notes on Design Patents," in Intellectual Property in the Technological Age, pp. 333-39 [Supp II 97-103]

 

 

A. Utility

• Lowell v. Lewis, 15 Fed. Cas. 1018 (C.C.D.Mass. 1817) [Supp III 1-2]
• Brenner v. Manson, 383 U.S. 519 (1966) [CNSNK 708-12]
• Notes [CNSNK 713-14]
• In re Brana, 51 F.3d 1560 (CAFC 1995)  [CNSNK 714-19]
• Notes [CNSNK 719-25]
• Clarisa Long, "The Brouhaha Over Expressed Sequence Tags" [CNSNK 725-27]

B. Novelty and Loss of Right

• 35 U.S.C. sec. 102 [Supp III 3-4]
• Introductory Note [CNSNK 323-26]
• Christopher Heath, "Grace Periods in the World" [CNSNK 336-40]
• Egbert v. Lippmann [CNSNK 340-43]
• Notes [CNSNK 346-47]
• Lough v. Brunswick Corporation [CNSNK 351-58]
• Notes [CNSNK 358-60]
• Manya Deehr & William Rooklidge, "The Stage of Development of an Invention Subject to the On-Sale Bar to Patentability" [CNSNK 372-82]
• Baxter International, Inc. v. COBE Laboratories, Inc. [CNSNK 385-91]
• Notes [CNSNK 391-93]
• In re Kathawala [CNSNK 394-99]
• Notes [CNSNK 399]
• Mahurkar v. C. R. Bard, Inc. [CNSNK 400-04]
• Notes [CNSNK 404-08]
• Minnesota Mining & Mfg. Co. v. Johnson & Johnson [CNSNK 408-09]
• In re Paulsen [CNSNK 410-12]
• Notes [CNSNK 412-15]
• Rosaire v. Baroid Sales Division [CNSNK 418-21]
• Notes [CNSNK 421-23]
• In re Hall [CNSNK 423-26]
• Notes [CNSNK 430-31]
• Alexander Milburn Co. v. Davis-Bournonville Co. [CNSNK 437-39]
• Notes [CNSNK 439-41 & 445-51]
• In re Hilmer (Hilmer I) [CNSNK 451-57]
• In re Hilmer (Hilmer II) [CNSNK 457-60]
• Notes [CNSNK 460-62]
• Gambro Lundia AB v. Baxter Healthcare Corp. [CNSNK 462-67]
• Notes [CNSNK 467]
• Fiers v. Revel [CNSNK 468-72]
• Notes [CNSNK 483-91]
• Notes on "Reduction to Practice" [CNSNK 499-501]
• Notes on Abandonment, Suppression, and Concealment [CNSNK 509-11]
• Advisory Commission on Patent Law Reform, "A Report to the Secretary of Commerce," 43-50 (1992) [G 313-23] [Supp III 5-15]
• Paul Goldstein, Notes on Priority Systems, in International Intellectual Property Law, 323-26 [Supp III 6-19]
• Stein Associates v. Heat and Control, Inc., 748 F.2d 653 (CAFC 1984) [G 326-30] [Supp III 20-24]
• Advisory Commission on Patent Law Reform, "A Report to the Secretary of Commerce," 65-66 (1992) [G 330-33] [Supp III 25-27]
• Paul Goldstein, Notes on Defensive Priority, in International Intellectual Property Law, 333-35 [Supp III 28-30]

C. Nonobviousness

• 35 U.S.C. sec. 103 [Supp III 31-32]
• Introductory Notes [CNSNK 514-19]
• Graham v. John Deere Co. [CNSNK 519-40]
• Notes [CNSNK 547-49]
• Tom Arnold, "The Way the Law of Section 103 was Made" [CNSNK 549-54]
• Roberts v. Sears, Roebuck & Co., 723 F.2d 1324 (7th Cir. 1983) (Posner, J., concurring and dissenting) [Supp III 33-35]
• Robert Nozick, Anarchy, State, and Utopia 178-82 (1974) [Supp III 36-38]
• In re Clay [CNSNK 554-57]
• In re Paulsen [CNSNK 557-59]
• Notes [CNSNK 559-61]
• Hazeltine Research, Inc. v. Brenner [CNSNK 561-63]
• Notes on 102(g)/103 Prior Art [CNSNK 575-78]
• OddzOn Products, Inc. v. Just Toys, Inc. [CNSNK 578-83]
• Notes [CNSNK 583-84]
• In re Dow Chemical Co. [CNSNK 585-88]
• Notes [CNSNK 593-97]
• Notes on the PHOSITA [CNSNK 597-600]
• Notes on Secondary Consideration [CNSNK 601-602, 606-12]
• In re Durden [CNSNK 683-86]
• In re Pleuddemann [CNSNK 686-91]
• Note on Congressional Response [CNSNK 692-93]
• In re Ochiai [CNSNK 693-701]
• Notes [CNSNK 701-06]
• Beier, "The Inventive Step," in Paul Goldstein, International Intellectual Property Law, 336-48 [Supp III 39-51]
• Paul Goldstein, Note 1 on Inventive Step, in International Intellectual Property Law, 348-49 [Supp III 52-53]

D. Disclosure

• Introductory Notes [CNSNK 161-62]
• Notes 1-2 on Disclosure Policy [CNSNK 170-71]
• In re Glass [CNSNK 172-78]
• Notes [CNSNK 178-82]
• Notes [CNSNK 190-93]
• Glaxo Inc. v. Novopharm Ltd [CNSNK 194-204]
• Notes [CNSNK 204-06]
• Great Northern Corp. v. Henry Molded Products, Inc. [CNSNK 206-10]
• Note [CNSNK 210-11]
• Notes 2-9 on Written Description [CNSNK 225-31]
• Athletic Alternatives, Inc. v. Prince Mfg., Inc [CNSNK 236-47]
• Notes [CNSNK 247-49]

E.  Procedures

• Notes on the Patent Applications and Procedures before the PTO [CNSNK 93-128]
• Charles L. Gholz, "Inteferences" [CNSNK 511-13]
• Robert Benson, "The Impact of the PCT and EPC on U.S. Practitioners," 60 Journal of the Patent Office Society 118-26 (1978) [G 353-58] [Supp III 54-59]
• Paul Goldstein, Notes on International Patent Practice, in International Intellectual Property Law, 358-62 [Supp III 60-64]
   
     

IV. Patent Entitlements

A. Infringement

• Introductory Notes [CNSNK 829-39]
• Mathew Powers et al., "The Successful Patent Litigator" [CNSNK 839-42]
• Markman v. Westview Instruments, Inc. (Markman II) [CNSNK 843-47]
• Notes [CNSNK 847-54]
• Vitronics Corp. v. Conceptronic, Inc. [CNSNK 856-65]
• Notes [CNSNK 865-70]
• Note on Equivalents [CNSNK 873-77]
• Warner-Jenkinson Company, Inc. v. Hilton Davis Chemical, Inc. [CNSNK 887-900]
• Notes [CNSNK 900-10]
• Notes on Prosecution History Estoppel [CNSNK 910-15]
• Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., Ltd. (S.Ct. 2002) [Supp IV 1-12]
• T.H.K. Co. Ltd. v. Tsubakimoto Seiko Co. Ltd. (Supreme Court of Japan, Feb. 24, 1998), CASRIP Newsletter, Winter 1998, 12 [G 411-19] [Supp IV 13-21]
• Paul Goldstein, Notes on International Variants of Equivalents Doctrine, in International Intellectual Property Law, 419-20 [Supp IV 22-23]
• C.R. Bard, Inc. v. Advanced Cardiovascular Systems, Inc. [CNSNK 951-53]
• Notes [CNSNK 953-55]
• Hewlett-Packard Company v. Bausch & Lomb, Inc. [CNSNK 955-60]
• Notes [CNSNK 960-62]
• Notes on Foreign Activity and Export Control [CNSNK 962-66]
• William Lee, "The Jury Trial of Patent Cases Involving Complex Technologies" [CNSNK 1020-24]
• Misrock & Kieff, "Latent Curses for patent Pathology: Do Our Civil Juries Promote Science and the Useful Arts?" [CNSNK 1024-38]
• Robert P. Merges & Richard M. Nelson, "On the Complex Economics of Patent Scope," 90 Colum. L. Rev. 839, 868-907 (1990) [Supp IV]

B. Limitations and Defenses

• Introductory Note [CNSNK 1042-43]
• Pasternak & Nelson, "Declaratory Judgment Jurisdiction" [CNSNK 1043-49]
• Note on Inequitable Conduct [CNSNK 1049-50]
• Kingsdown Med. Consultants, Ltd. v. Hollister, Inc [CNSNK 1050-58]
• Notes [CNSNK 1058-59]
• Notes [CNSNK 1064-66]
• Note on Misuse and § 271(d) [CNSNK 1066-67]
• Dawson Chemical v. Rohm and Haas [CNSNK 1068-87]
• Notes [CNSNK 1087]
• Mallinckrodt v. Medipart [CNSNK 1087-95]
• Notes [CNSNK 1095-97]
• Nobelpharma AB v. Implant Innovations, Inc. [CNSNK 1099-1110]
• Notes [CNSNK 1100-15]
• Gajarsa & Cianfrani, "At the Intersection of Patent Law and Antitrust Law" [CNSNK 1115-18]
• Note on The Doctrine of First Sale [CNSNK 1118-21]
• Heath, "National and International Exhaustion" [CNSNK 1121-29]
• Merck & Co. v. Stephar B.V., Case 187/80, [1981] ECR 2063, G 373-76 [Supp IV 41-44]
• Paul Goldstein, Note 4 on Exhaustion, in International Intellectual Property Law, 377-78 [Supp IV 45-47]
• Note on Implied Licenses [CNSNK 1128-30]
• Notes on the First Inventor Defense [CNSNK 1196-1204]
• Madey v. Duke University, 307 F.3d 1351 (CAFC 2002) [handout]
• Carlos Correa, "The GATT Agreement on Trade-Related Aspects of Intellectual Property Rights:  New Standards for Patent Protection," 16 European Intellectual Property Review 327, 330-33 (1994) [Supp IV 48-52]
• Report of WTO Panel, WT/DS114/R, 17 March 2000 [G 384-400] [Supp IV 53-68]
• Notes on TRIPS Restrictions on Patent Limitations [Supp IV 69-71]

 

C. Remedies

• Introductory Note [CNSNK 1223]
• Janicke, "Remedies for Patent Infringement" [CNSNK 1223-25]
• Panduit Corp. v. Stahlin Bros. Fibre Works [CNSNK 1226-29]
• Notes [CNSNK 1229-34, 1241-43]
• Georgia-Pacific Corp. v. United States Plywood Corp. [CNSNK 1243-51]
• Notes [CNSNK 1252-53, 1257-58]
• Notes on Attorney Fees, Enhanced Damages, Willfulness and Notice [CNSNK 1279-87]
• Note on Injunctions [CNSNK 1287-97]
• Smith Int'l, Inc. v. Hughes Tool Co. [CNSNK 1289-97]
• Notes [CNSNK 1297-1300]
• Notes [CNSNK 1302-03]

 

V. International Patent Problems

A. Pharmaceutical Patents and Public-Health Emergencies

• George Foster, "Opposing Forces in a Revolution in International Patent Protection: The U.S. and India in the Uruguay Round and Its Aftermath," 3 UCLA Journal of International Law and Foreign Affairs 283, 296-322 (1998) [Supp V 1-13]
• M. Kremer, "Pharmaceuticals and the Developing World," 16 Journal of Economic Perspectives 67 (2002) [Supp V 14-37]
• Park, "The International Drug Industry: What the Future Holds for South Africa's HIV/AIDS Patients," 11 Minn. J. Global Trade 125 (2002) [Supp V 38-49]

B. Bioprospecting

• William Fisher, "Managing Genetic Resources," in Legal Reform in Central America (Kennedy School of Government 2001) [Supp V 50-65]
• Charles R. McManis, "Intellectual Property, Genetic Resources, and Traditional Knowledge Protection: Thinking Globally, Acting Locally," 11 Cardozo J. Int'l & Comp. L. 547, 565-80 (2003) [Supp V 66-77]

C. A Global Patent System?

• Gerald Mossinghoff & Vivian Kuo, "World Patent System Circa 20XX, A.D." 38 Idea 529 (1998) [Supp V 78-96]

   

VI. Assessing the System

• Steven Shavell and Tanguy van Ypersele, "Rewards versus Intellectual Property Rights," 44 J. of Law & Economics 525 (2001) [F 431-445] [Supp VI 1-18]
• "The Patent Wars," The Economist, April 18, 2000, 75-78 [Supp VI 19-22]
• "More Patents Please!," Wall Street Journal, October 3, 2002 [Supp VI 23-25]
• Michael Heller and Rebecca Eisenberg, "Can Patents Deter Innovation? The AntiCommons in Biomedical Research," 280 Science 698 (1998) [Supp VI 26-29]
• J.H. Barton, "Reforming the Patent System," 287 Science 1933 (2000) [Supp VI 30-33]
• L.C. Thurow, "Needed: A New System of Intellectual Property Rights," Harvard Business Review 95 (1997) [Supp VI 34-43]

William Fisher

Email: tfisher@law.harvard.edu
Homepage: tfisher.org